Cuadra, Merliza A.

HRN: 27-62-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
AMPICILLIN 1GM (VIAL)
08/13/2025
08/16/2025
IV
2g
Q6
PPROM
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines